The event has now run!
Returning in 2025
Accelerate collaboration and partnering across neurology and psychiatry pipelines and technologies, to reduce risk, validate technologies, and deliver better biodistribution of safe and efficacious molecules to the CNS
ATTENDEES INCLUDED
Key Figures from Partnering Series
meetings through the partnering portal
acceptance rate of meetings, versus 11% industry standard
total attendees, including: 20+ pharma, 65+ biotech
companies
director level and above
Size of Networking Opportunity
Total Audience Networking
Creating Alignment Through Targeted Critical Mass:
Exclusive to the neuroscience pharma, biotech, and investor community, you are guaranteed a greater number of strategically matched interactions when networking candidly. Free from CROs/CDMOs or other service providers, maximize speaking with the highest priority contacts for your company while they and you are free from conflicting priorities.
Interested Group Matchmaking & Speed Dating
Group Matchmaking & “Speed Dating” Style Networking
Tell us which pharma you want to meet in advance, and we will coordinate face-to-face, sit-down meetings with them during protected networking time at the pharma matchmaking tables on day one.
With speed networking then running on the morning of day two, be certain you have met every other attendee and have the opportunity to reconnect before the conference finishes.
Individual Meetings: One-on-One Partnering™
The industry’s favorite partnering portal, search the full attendee list, message and pre-schedule meetings in calendars ahead of the conference, and automatically book private meeting spaces: the most efficient way to set yourself up for success.
EXPERT SPEAKERS INCLUDED:
Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy
AbbVie
Jenny Laird
Vice President, Search & Evaluation Neuroscience
Eli Lilly
Vidya Nadar
Director, Search & Evaluation, Rare & Neurological Disorders
Sanofi
David Donabedian
Executive Partner
Longwood Fund
Stacie Weninger
President
F-Prime Capital
OTHER HANSON WADE SUMMITS
